Polymorphisms and pharmacogenomics for the toxicity of methotrexate monotherapy in patients with rheumatoid arthritis: A systematic review and meta-analysis

BACKGROUND: Methotrexate (MTX) is widely used and considered a first-line disease modifying antirheumatic drug (DMARD) for the treatment of rheumatoid arthritis (RA). However, 10% to 30% of patients discontinue therapy within a year of starting the treatment, usually because of undesirable side effe...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Medicine (Baltimore)
Autors principals: Qiu, Qi, Huang, Jing, Lin, Yang, Shu, Xiaoming, Fan, Huizheng, Tu, Zhihua, Zhou, Youwen, Xiao, Cheng
Format: Artigo
Idioma:Inglês
Publicat: Wolters Kluwer Health 2017
Matèries:
4400
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5369916/
https://ncbi.nlm.nih.gov/pubmed/28296761
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000006337
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars